Polyrizon’s ground breaking proprietary engineering uncovered effective versus coronavirus in a pre-clinical review

Polyrizon’s formulations demonstrated significant efficacy by avoiding coronavirus from interacting with epithelial host cells and by inhibiting cells’ dying

OMER, Israel, July 23, 2021 (World NEWSWIRE) — Medigus Ltd. (Nasdaq: MDGS), a engineering business engaged in state-of-the-art clinical answers, innovative world-wide-web systems and electric powered motor vehicle and charging alternatives, these days introduced that Polyrizon Ltd., a privately held business (which Medigus owns 33.24% of its share capital) engaged in acquiring very differentiated biological gels for the goal of defending individuals in opposition to organic threats and external pathogens, reported pre-clinical information from its formerly declared pre-medical research exhibiting that

Read more Read More